Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus
Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US..
From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2016 |
|---|---|
| Erschienen: |
2016 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:63 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 63(2016), 3 vom: 01. Aug., Seite 376-9 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wong, Karen K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Ebola virus |
|---|
| Anmerkungen: |
Date Completed 14.03.2018 Date Revised 13.11.2018 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciw256 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM259778729 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM259778729 | ||
| 003 | DE-627 | ||
| 005 | 20231224191934.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciw256 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0865.xml |
| 035 | |a (DE-627)NLM259778729 | ||
| 035 | |a (NLM)27118786 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wong, Karen K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus |
| 264 | 1 | |c 2016 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.03.2018 | ||
| 500 | |a Date Revised 13.11.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US. | ||
| 520 | |a From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, U.S. Gov't, P.H.S. | |
| 650 | 4 | |a Ebola virus | |
| 650 | 4 | |a TKM-Ebola | |
| 650 | 4 | |a postexposure prophylaxis | |
| 650 | 4 | |a vesicular stomatitis virus | |
| 700 | 1 | |a Davey, Richard T |c Jr |e verfasserin |4 aut | |
| 700 | 1 | |a Hewlett, Angela L |e verfasserin |4 aut | |
| 700 | 1 | |a Kraft, Colleen S |e verfasserin |4 aut | |
| 700 | 1 | |a Mehta, Aneesh K |e verfasserin |4 aut | |
| 700 | 1 | |a Mulligan, Mark J |e verfasserin |4 aut | |
| 700 | 1 | |a Beck, Allison |e verfasserin |4 aut | |
| 700 | 1 | |a Dorman, William |e verfasserin |4 aut | |
| 700 | 1 | |a Kratochvil, Christopher J |e verfasserin |4 aut | |
| 700 | 1 | |a Lai, Lilin |e verfasserin |4 aut | |
| 700 | 1 | |a Palmore, Tara N |e verfasserin |4 aut | |
| 700 | 1 | |a Rogers, Susan |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Philip W |e verfasserin |4 aut | |
| 700 | 1 | |a Suffredini, Anthony F |e verfasserin |4 aut | |
| 700 | 1 | |a Wolcott, Mark |e verfasserin |4 aut | |
| 700 | 1 | |a Ströher, Ute |e verfasserin |4 aut | |
| 700 | 1 | |a Uyeki, Timothy M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 63(2016), 3 vom: 01. Aug., Seite 376-9 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:63 |g year:2016 |g number:3 |g day:01 |g month:08 |g pages:376-9 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciw256 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 63 |j 2016 |e 3 |b 01 |c 08 |h 376-9 | ||